GLENMARK GENERICS (EUROPE) LIMITED29 November 2013
GLENMARK PHARMACEUTICALS (EUROPE) LIMITED26 November 2007
GLENMARK PHARMACEUTICALS (UK) LTD14 September 2006
FAQs
Frequently Asked Questions
Detailed answers about GLENMARK PHARMACEUTICALS EUROPE LIMITED, including incorporation, status, business activity, and accounts information.
When was GLENMARK PHARMACEUTICALS EUROPE LIMITED founded?
GLENMARK PHARMACEUTICALS EUROPE LIMITED was officially incorporated on 10 February 2004 and is registered under company number 05040260. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GLENMARK PHARMACEUTICALS EUROPE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GLENMARK PHARMACEUTICALS EUROPE LIMITED?
GLENMARK PHARMACEUTICALS EUROPE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GLENMARK PHARMACEUTICALS EUROPE LIMITED do?
GLENMARK PHARMACEUTICALS EUROPE LIMITED operates in the following sector: 46460 - Wholesale of pharmaceutical goods. This provides insight into the company's primary business activity and industry focus.
What is GLENMARK PHARMACEUTICALS EUROPE LIMITED's registered address?
The registered office address of GLENMARK PHARMACEUTICALS EUROPE LIMITED is 2-B LAXMI HOUSE, DRAYCOTT AVENUE KENTON, HARROW, MIDDLESEX, HA3 0BU. This is the official address filed with Companies House for legal and statutory correspondence.
Is GLENMARK PHARMACEUTICALS EUROPE LIMITED financially stable?
The most recent accounts for GLENMARK PHARMACEUTICALS EUROPE LIMITED were made up to 31 March 2025, filed as FULL. Next accounts are due by 31 December 2026.
Does GLENMARK PHARMACEUTICALS EUROPE LIMITED have any charges or mortgages?
GLENMARK PHARMACEUTICALS EUROPE LIMITED has 3 registered charges, of which 2 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.
Has GLENMARK PHARMACEUTICALS EUROPE LIMITED changed its name?
Yes, GLENMARK PHARMACEUTICALS EUROPE LIMITED has had 3 previous names: GLENMARK GENERICS (EUROPE) LIMITED (changed 29 November 2013), GLENMARK PHARMACEUTICALS (EUROPE) LIMITED (changed 26 November 2007), GLENMARK PHARMACEUTICALS (UK) LTD (changed 14 September 2006).